Peak Pharmaceuticals (PKPH) Stock Price, News & Analysis

Company Overview

Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Key Stats

• Today's Range: $1.98 to $2.94
• 50-Day Range: $2.48 to $6.77
• 52-Week Range: $0.52 to $9.12
• Volume: 1,942 shs
• Average Volume: 9,053 shs
• Market Capitalization: $980,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PKPH Stock Analysis - Frequently Asked Questions

How have PKPH shares performed this year?

Peak Pharmaceuticals' stock was trading at $1.07 at the beginning of 2025. Since then, PKPH shares have increased by 133.6% and is now trading at $2.50.
View the best growth stocks for 2025 here.

How do I buy shares of Peak Pharmaceuticals?

Shares of PKPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Peak Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Peak Pharmaceuticals investors own include Ginkgo Bioworks (DNA), Jazz Pharmaceuticals (JAZZ), Medical Marijuana (MJNA), Altria Group (MO), OPKO Health (OPK), GrowLife (PHOT) and RTX (RTX).

Company Calendar

• Today: 5/18/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:PKPH
• CIK: 1452804
• Web: www.peakpharma.com
• Phone: (480) 659-6404
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-160,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -159.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.15
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 392,000
• Free Float: 320,000
• Market Cap: $980,000.00
• Optionable: Not Optionable
• Beta: 0.54